These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
65 related articles for article (PubMed ID: 1727223)
1. Drug promotion and scientific exchange. Ozols RF N Engl J Med; 1992 Jan; 326(2):134. PubMed ID: 1727223 [No Abstract] [Full Text] [Related]
2. Drug promotion and scientific exchange. Blue BA N Engl J Med; 1992 Jan; 326(2):133; author reply 134. PubMed ID: 1727222 [No Abstract] [Full Text] [Related]
3. Drug promotion and scientific exchange. Vogel RM N Engl J Med; 1992 Jan; 326(2):134. PubMed ID: 1727224 [No Abstract] [Full Text] [Related]
4. Drug promotion and scientific exchange. Blackwell RE N Engl J Med; 1992 Jan; 326(2):133; author reply 134. PubMed ID: 1727221 [No Abstract] [Full Text] [Related]
5. Drug promotion and scientific exchange. Wilbur RS N Engl J Med; 1992 Jan; 326(2):133-4. PubMed ID: 1550609 [No Abstract] [Full Text] [Related]
6. Is drug advertising informing the consumer? Hanlon PM Behav Healthc Tomorrow; 2002 Feb; 11(1):SR35-7. PubMed ID: 11837141 [No Abstract] [Full Text] [Related]
7. Direct-to-consumer prescription drug advertising. Terzian TV Am J Law Med; 1999; 25(1):149-67. PubMed ID: 10207573 [No Abstract] [Full Text] [Related]
8. Marketing drug information to corporations. Kimelblatt BJ; Kucich JM; Silverman HM; Simon GI Am J Hosp Pharm; 1982 Feb; 39(2):313-4. PubMed ID: 7058808 [No Abstract] [Full Text] [Related]
10. Stoning a dead bird: advertising limits on approved new drugs. Strobos J Food Drug Law J; 1995; 50(4):533-51. PubMed ID: 10343018 [No Abstract] [Full Text] [Related]
11. Peddling drugs to docs. Heussner RC Minn Med; 1994 Jun; 77(6):24-31. PubMed ID: 8041331 [No Abstract] [Full Text] [Related]
12. A closer look at drug promotion. Birkey TG Minn Med; 1994 Sep; 77(9):2. PubMed ID: 7968947 [No Abstract] [Full Text] [Related]
14. A defense of the learned intermediary doctrine. Goetz RB; Growdon KR Food Drug Law J; 2008; 63(2):421-38. PubMed ID: 18561470 [No Abstract] [Full Text] [Related]
15. [Drug information: a company convicted for advertising without permission from the Medical Products Agency]. Lakartidningen; 1997 Feb; 94(6):449. PubMed ID: 9053698 [No Abstract] [Full Text] [Related]
16. Recent developments in direct consumer advertising of attention disorder stimulants and creating limits to withstand constitutional scrutiny. Strawn MN J Contemp Health Law Policy; 2003; 19(2):495-520. PubMed ID: 14748255 [No Abstract] [Full Text] [Related]
17. Educating health professionals about drug and device promotion: a Nepalese perspective. Shankar PR PLoS Med; 2007 Feb; 4(2):e89; author reply e88. PubMed ID: 17326721 [No Abstract] [Full Text] [Related]
18. Comment: the economics of direct-to-consumer advertising of prescription-only drugs: prescribed to improve consumer welfare? Rosenthal M J Health Serv Res Policy; 2004 Jan; 9(1):39-42; discussion 41-2. PubMed ID: 15006239 [No Abstract] [Full Text] [Related]
19. The economics of direct-to-consumer advertising of prescription-only drugs: prescribed to improve consumer welfare? Morgan S; Mintzes B; Barer M J Health Serv Res Policy; 2003 Oct; 8(4):237-44. PubMed ID: 14596759 [TBL] [Abstract][Full Text] [Related]
20. Getting the most out of advertising and promotion. Abraham MM; Lodish LM Harv Bus Rev; 1990; 68(3):50-1, 53, 56 passim. PubMed ID: 10106591 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]